- Home
- RELL vs MRSN Comparison
RELL vs MRSN Comparison
Compare RELL & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- MRSN
- Stock Information
- Founded
- RELL 1947
- MRSN 2001
- Country
- RELL United States
- MRSN United States
- Employees
- RELL N/A
- MRSN N/A
- Industry
- RELL Electronic Components
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- MRSN Health Care
- Exchange
- RELL Nasdaq
- MRSN Nasdaq
- Market Cap
- RELL 149.6M
- MRSN 138.6M
- IPO Year
- RELL N/A
- MRSN 2017
- Fundamental
- Price
- RELL $10.05
- MRSN $27.40
- Analyst Decision
- RELL
- MRSN Buy
- Analyst Count
- RELL 0
- MRSN 5
- Target Price
- RELL N/A
- MRSN $30.38
- AVG Volume (30 Days)
- RELL 57.4K
- MRSN 233.0K
- Earning Date
- RELL 01-06-2026
- MRSN 11-14-2025
- Dividend Yield
- RELL 2.35%
- MRSN N/A
- EPS Growth
- RELL N/A
- MRSN N/A
- EPS
- RELL 0.01
- MRSN N/A
- Revenue
- RELL $209,791,000.00
- MRSN $33,180,000.00
- Revenue This Year
- RELL $4.72
- MRSN N/A
- Revenue Next Year
- RELL $14.93
- MRSN N/A
- P/E Ratio
- RELL $835.11
- MRSN N/A
- Revenue Growth
- RELL 6.17
- MRSN N/A
- 52 Week Low
- RELL $7.57
- MRSN $5.21
- 52 Week High
- RELL $15.51
- MRSN $70.73
- Technical
- Relative Strength Index (RSI)
- RELL 48.63
- MRSN 86.52
- Support Level
- RELL $9.37
- MRSN $27.15
- Resistance Level
- RELL $10.28
- MRSN $27.79
- Average True Range (ATR)
- RELL 0.46
- MRSN 0.67
- MACD
- RELL -0.06
- MRSN 1.12
- Stochastic Oscillator
- RELL 58.84
- MRSN 96.35
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.